Wedbush Lowers Earnings Estimates for Healthpeak Properties

Healthpeak Properties, Inc. (NYSE:DOC) – Research analysts at Wedbush dropped their FY2026 EPS estimates for Healthpeak Properties in a report issued on Monday, April 28th. Wedbush analyst R. Anderson now forecasts that the real estate investment trust will post earnings of $1.95 per share for the year, down from their previous estimate of $1.96. Wedbush has a “Outperform” rating and a $22.00 price target on the stock. The consensus estimate for Healthpeak Properties’ current full-year earnings is $1.86 per share.

Other analysts have also recently issued reports about the stock. Robert W. Baird reduced their price objective on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research note on Tuesday, February 11th. StockNews.com lowered Healthpeak Properties from a “hold” rating to a “sell” rating in a research note on Wednesday, April 23rd. Morgan Stanley raised Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price target for the company in a report on Wednesday, January 15th. Evercore ISI dropped their price target on Healthpeak Properties from $23.00 to $21.00 and set an “outperform” rating on the stock in a research note on Monday. Finally, Scotiabank cut their price target on Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating on the stock in a research report on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, Healthpeak Properties currently has an average rating of “Moderate Buy” and a consensus target price of $23.45.

Healthpeak Properties Price Performance

Shares of DOC opened at $17.77 on Tuesday. Healthpeak Properties has a 1-year low of $17.33 and a 1-year high of $23.26. The firm has a fifty day simple moving average of $19.53 and a two-hundred day simple moving average of $20.53. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96. The firm has a market cap of $12.43 billion, a PE ratio of 50.77, a P/E/G ratio of 2.17 and a beta of 1.02.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.46. The company had revenue of $702.89 million during the quarter, compared to analyst estimates of $690.76 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 9.00%. The firm’s revenue for the quarter was up 15.9% on a year-over-year basis. During the same quarter last year, the company earned $0.45 EPS.

Healthpeak Properties Dividend Announcement

The firm also recently declared a dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Friday, April 18th will be paid a dividend of $0.1017 per share. The ex-dividend date of this dividend is Thursday, April 17th. This represents a yield of 6.5%. Healthpeak Properties’s dividend payout ratio (DPR) is presently 305.00%.

Insider Buying and Selling

In other news, Director John T. Thomas bought 4,200 shares of the stock in a transaction that occurred on Monday, April 28th. The stock was purchased at an average price of $17.84 per share, for a total transaction of $74,928.00. Following the completion of the purchase, the director now owns 813,566 shares in the company, valued at approximately $14,514,017.44. This trade represents a 0.52 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Scott M. Brinker bought 11,337 shares of the business’s stock in a transaction dated Monday, April 28th. The shares were purchased at an average price of $17.68 per share, for a total transaction of $200,438.16. Following the transaction, the chief executive officer now directly owns 201,863 shares of the company’s stock, valued at approximately $3,568,937.84. This represents a 5.95 % increase in their position. The disclosure for this purchase can be found here. 0.23% of the stock is owned by insiders.

Hedge Funds Weigh In On Healthpeak Properties

Hedge funds have recently bought and sold shares of the stock. Parallel Advisors LLC lifted its stake in shares of Healthpeak Properties by 4.2% during the 1st quarter. Parallel Advisors LLC now owns 13,980 shares of the real estate investment trust’s stock worth $283,000 after purchasing an additional 561 shares during the period. AdvisorNet Financial Inc boosted its position in shares of Healthpeak Properties by 34.5% in the fourth quarter. AdvisorNet Financial Inc now owns 2,193 shares of the real estate investment trust’s stock worth $44,000 after acquiring an additional 563 shares during the last quarter. Townsquare Capital LLC grew its holdings in Healthpeak Properties by 5.9% in the fourth quarter. Townsquare Capital LLC now owns 10,461 shares of the real estate investment trust’s stock valued at $212,000 after purchasing an additional 584 shares during the period. Exchange Traded Concepts LLC increased its position in Healthpeak Properties by 10.0% during the fourth quarter. Exchange Traded Concepts LLC now owns 6,560 shares of the real estate investment trust’s stock worth $133,000 after purchasing an additional 598 shares during the last quarter. Finally, Huntington National Bank boosted its holdings in shares of Healthpeak Properties by 3.0% in the 4th quarter. Huntington National Bank now owns 20,843 shares of the real estate investment trust’s stock valued at $422,000 after purchasing an additional 613 shares during the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.